Quetiapine is classified as an atypical antipsychotic agent that functions by modulating neurotransmitter activity in the brain. Its primary therapeutic purpose is to manage symptoms of psychosis such as delusions and hallucinations in schizophrenia. It is also prescribed to stabilize mood episodes in bipolar i disorder both during manic and depressive phases. The drug exerts its pharmacological effect by antagonizing dopamine d2 receptors and serotonin 5-ht2a receptors. Antagonism at these receptors leads to reduced excitatory neurotransmission in cortical and subcortical pathways. This receptor profile results in dampened neuronal firing rates that are associated with psychotic and mood symptoms. Additional activity at histamine h1 and alpha-1 adrenergic receptors contributes to its sedative properties that can aid sleep in patients with agitation. Overall the medication's mechanism involves a balance of dopaminergic blockade and serotonergic modulation that produces both antipsychotic and mood-stabilizing outcomes.

Quetiapine is an atypical antipsychotic medication used primarily to treat symptoms of schizophrenia and bipolar disorder. It works by modulating the activity of several neurotransmitter receptors, including dopamine d2 and serotonin 5-ht2a receptors, which helps regulate mood and perception. The drug also blocks histamine h1 receptors, contributing to its sedative effect and making it useful for managing agitation. Quetiapine's affinity for alpha-1 adrenergic receptors produces antihistaminic and anti-adrenergic actions that can lower blood pressure and improve sleep quality. By influencing serotonergic pathways, it enhances emotional stability and reduces the intensity of manic episodes. The medication's pharmacokinetics allow for once-daily dosing, with steady plasma concentrations achieved after several days of treatment. Clinical studies have shown that it can reduce psychotic symptoms such as hallucinations and delusions while also decreasing the frequency of mood swings in bipolar patients. Overall, Quetiapine's dual antagonism of dopamine and serotonin receptors, combined with its antihistaminic properties, underlies its therapeutic role in stabilizing mood and controlling psychotic features.

Quetiapine may cause drowsiness and fatigue in some patients. It can lead to dizziness or light-headedness especially when standing quickly. Weight gain is reported as a common side effect. Elevated blood sugar levels have been observed in certain individuals. Some people experience constipation, dry mouth, or blurred vision. Less frequently, the medication can affect heart rhythm or cause irregular heartbeat. Psychological changes such as mood swings or irritability may occur. These effects are generally mild to moderate and often improve with continued use.

Quetiapine may cause drowsiness or sedation that can affect daily activities. Some individuals experience dizziness or light-headedness upon standing quickly. Weight gain is reported by many patients using the medication. Changes in blood sugar levels can occur, potentially influencing metabolic health. Dry mouth and constipation are common gastrointestinal side effects. In rare cases, irregular heart rhythm or palpitations have been observed. Headache and blurred vision may appear during treatment. Emotional blunting or reduced motivation are noted in a small proportion of users.